{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:08:52Z","timestamp":1787782132385,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005620","name":"North Carolina GlaxoSmithKline Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.coi.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T09:31:36Z","timestamp":1604655096000},"page":"129-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Hypersensitivity pneumonitis, allergic bronchopulmonary aspergillosis and other eosinophilic lung diseases"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6519-4609","authenticated-orcid":false,"given":"Jeffrey","family":"Barry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Gadre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Akuthota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2020.10.005_bib0005","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1164\/rccm.200409-1205WS","article-title":"Needs and opportunities for research in hypersensitivity pneumonitis","volume":"171","author":"Fink","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2020.10.005_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1378\/chest.11-2479","article-title":"Recent advances in hypersensitivity pneumonitis","volume":"142","author":"Lacasse","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.coi.2020.10.005_sbref0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chest.2018.08.1076","article-title":"Hypersensitivity pneumonitis: radiologic phenotypes are associated with distinct survival time and pulmonary function trajectory","volume":"155","author":"Salisbury","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.coi.2020.10.005_bib0020","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201611-2201PP","article-title":"Hypersensitivity pneumonitis: perspectives in diagnosis and management","volume":"196","author":"Vasakova","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2020.10.005_bib0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5858\/arpa.2017-0138-SA","article-title":"Hypersensitivity pneumonitis: a perspective from members of the pulmonary pathology society","volume":"142","author":"Miller","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.coi.2020.10.005_bib0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.201203-0513CI","article-title":"Hypersensitivity pneumonitis: insights in diagnosis and pathobiology","volume":"186","author":"Selman","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2020.10.005_bib0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5858\/arpa.2017-0173-RA","article-title":"Pathology of chronic hypersensitivity pneumonitis: what is it? What are the diagnostic criteria? Why do we care?","volume":"142","author":"Churg","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.coi.2020.10.005_bib0040","first-page":"1","article-title":"Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis","volume":"3","author":"Adegunsoye","year":"2017","journal-title":"ERS Monogr"},{"key":"10.1016\/j.coi.2020.10.005_bib0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/CMR.00025-12","article-title":"Eosinophilic pneumonias","volume":"25","author":"Akuthota","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coi.2020.10.005_bib0050","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1172\/JCI118675","article-title":"T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis","volume":"97","author":"Chauhan","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2020.10.005_bib0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1378\/chest.116.3.639","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific advisory group, investigators, and coordinators of the epidemiologic study of cystic fibrosis","volume":"116","author":"Geller","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.coi.2020.10.005_bib0060","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1378\/chest.07-0808","article-title":"Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients","volume":"132","author":"Agarwal","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.coi.2020.10.005_bib0065","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/archinte.1986.00360170130020","article-title":"Allergic bronchopulmonary aspergillosis","volume":"146","author":"Patterson","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.coi.2020.10.005_bib0070","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"ABPA complicating asthma ISHAM working group: allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"Suppl. 3","key":"10.1016\/j.coi.2020.10.005_bib0075","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2014state of the art: cystic fibrosis foundation consensus conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2020.10.005_bib0080","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2020.10.005_bib0085","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"Stevens","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2020.10.005_bib0090","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx040","article-title":"Successful treatment of allergic bronchopulmonary aspergillosis with isavuconazole: case report and review of the literature","volume":"4","author":"Jacobs","year":"2017","journal-title":"Open forum Infect Dis"},{"key":"10.1016\/j.coi.2020.10.005_bib0095","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaip.2014.12.008","article-title":"Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis","volume":"3","author":"Voskamp","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.coi.2020.10.005_sbref0100","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009688","article-title":"Drug-induced eosinophilic pneumonia: a review of 196 case reports","volume":"97","author":"Bartal","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.coi.2020.10.005_bib0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-2006-939522","article-title":"Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia","volume":"27","author":"Solomon","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.coi.2020.10.005_bib0110","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF02079221","article-title":"Zur Differential-Diagnose der Lungeninfiltrierungen","volume":"79","author":"L\u00f6ffler","year":"1932","journal-title":"Beitr Klin Tuberk Spezif Tuberkuloseforsch"},{"key":"10.1016\/j.coi.2020.10.005_bib0115","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1378\/chest.91.5.734","article-title":"Pulmonary eosinophilia in coccidioidal infections","volume":"91","author":"Lombard","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.coi.2020.10.005_sbref0120","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1164\/rccm.201710-1967CI","article-title":"Acute eosinophilic pneumonia. Causes, diagnosis, and management","volume":"197","author":"De Giacomi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2020.10.005_bib0125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1183\/09031936.00221811","article-title":"Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia","volume":"41","author":"Rhee","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coi.2020.10.005_bib0130","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-1-11","article-title":"Idiopathic chronic eosinophilic pneumonia","volume":"1","author":"Marchand","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.coi.2020.10.005_bib0135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1378\/chest.103.1.162","article-title":"Chronic eosinophilic pneumonia; a long-term follow-up of 12 patients","volume":"103","author":"Naughton","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.coi.2020.10.005_bib0140","first-page":"5","article-title":"2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides","author":"Jennette","year":"2012","journal-title":"Revmatologiia (Bulgaria)"},{"key":"10.1016\/j.coi.2020.10.005_bib0145","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1183\/13993003.00097-2016","article-title":"Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"48","author":"Cottin","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coi.2020.10.005_bib0150","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2020.10.005_bib0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.autrev.2014.12.004","article-title":"Churg-Strauss syndrome","volume":"14","author":"Greco","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2020.10.005_bib0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2014.01.018","article-title":"Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome)","volume":"48\u201349","author":"Mouthon","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2020.10.005_sbref0165","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2020.10.005_sbref0170","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/rccm.201804-0809OC","article-title":"Sputum antineutrophil cytoplasmic antibodies in serum antineutrophil cytoplasmic antibody\u2013negative eosinophilic granulomatosis with polyangiitis","volume":"199","author":"Mukherjee","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2020.10.005_bib0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejim.2016.09.014","article-title":"Comprehensive evaluation of cardiac involvement in eosinophilic granulomatosis with polyangiitis (EGPA) with cardiac magnetic resonance","volume":"39","author":"Cereda","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.coi.2020.10.005_bib0180","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/annrheumdis-2014-206095","article-title":"Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"75","author":"Mohammad","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2020.10.005_bib0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2010.03.042","article-title":"Refining the definition of hypereosinophilic syndrome","volume":"126","author":"Simon","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2020.10.005_bib0190","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12016-015-8506-7","article-title":"Hypereosinophilic syndrome","volume":"50","author":"Curtis","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.coi.2020.10.005_sbref0195","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa1812185","article-title":"Benralizumab for PDGFRA-negative hypereosinophilic syndrome","volume":"380","author":"Kuang","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791520300996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791520300996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:46:36Z","timestamp":1760604396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791520300996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":39,"alternative-id":["S0952791520300996"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2020.10.005","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypersensitivity pneumonitis, allergic bronchopulmonary aspergillosis and other eosinophilic lung diseases","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}